Sono Toi Selected Research

Cerebral Arterial Diseases

7/2022

Effects of Pemafibrate in Patients with Stroke and Hypertriglyceridemia: Baseline Cerebral Artery Diseases and 3-Month Laboratory Outcomes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sono Toi Research Topics

Disease

6	Stroke (Strokes) 09/2022 - 05/2014
3	Pathologic Constriction (Stenosis) 07/2022 - 01/2015
3	Ischemic Stroke 01/2022 - 05/2014
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 08/2008 - 09/2004
2	Hypertriglyceridemia 07/2022 - 01/2022
2	Dyslipidemias (Dyslipidemia) 07/2022 - 05/2014
2	Atherosclerosis 07/2022 - 12/2009
2	Cerebral Infarction 08/2021 - 12/2007
2	Atherosclerotic Plaque (Atheroma) 12/2009 - 12/2007
1	Exotropia (Exophoria) 07/2022
1	Paralysis (Palsy) 07/2022
1	Ocular Motility Disorders (Convergence Insufficiency) 07/2022
1	Cerebral Arterial Diseases 07/2022
1	Acute Coronary Syndrome 04/2022
1	Mucormycosis 08/2021
1	Carotid Artery Thrombosis 08/2021
1	Hemiplegia (Spastic Hemiplegia) 02/2019
1	Tuberculoma 01/2017
1	Neurocysticercosis 01/2017
1	Diabetes Mellitus 05/2014
1	Embolic Stroke 05/2014
1	Atrial Fibrillation 05/2014
1	Coronary Artery Disease (Coronary Atherosclerosis) 05/2014
1	Hypertension (High Blood Pressure) 05/2014
1	Multiple System Atrophy 05/2010
1	Neuroinflammatory Diseases 05/2010
1	Inflammation (Inflammations) 08/2008
1	Carotid Artery Diseases 12/2007
1	Neuroblastoma 01/2006
1	Neoplasms (Cancer) 01/2006

Drug/Important Bio-Agent (IBA)

2	omega-Chloroacetophenone (Mace)IBA 09/2022 - 04/2022
2	Triglycerides (Triacylglycerol)IBA 07/2022 - 01/2022
2	EnzymesIBA 07/2022 - 09/2004
2	Cilostazol (Pletal)FDA LinkGeneric 01/2022 - 01/2015
2	Proteins (Proteins, Gene)FDA Link 02/2007 - 09/2004
1	(R)-2-(3-((benzoxazol-2-yl-d4 (3- (4- methoxyphenoxy- d7)propyl)amino)methyl)phenoxy) butanoic acidIBA 07/2022
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 07/2022
1	PPAR alphaIBA 07/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	LDL CholesterolIBA 01/2022
1	ParaffinIBA 08/2021
1	SteroidsIBA 02/2019
1	Acyclovir (Aciclovir)FDA LinkGeneric 02/2019
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 02/2019
1	Adenosine DeaminaseIBA 01/2017
1	GadoliniumIBA 01/2017
1	Praziquantel (Biltricide)FDA Link 01/2017
1	Interferon-gamma (Interferon, gamma)IBA 01/2017
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2015
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2015
1	danaparoid (Orgaran)FDA Link 05/2014
1	AnticoagulantsIBA 05/2014
1	Brain Natriuretic Peptide (Natrecor)FDA Link 05/2014
1	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 05/2010
1	SynucleinsIBA 05/2010
1	Phosphatidylcholines (Phosphatidylcholine)IBA 12/2009
1	AcidsIBA 12/2009
1	13-hydroxy-9,11-octadecadienoic acidIBA 12/2009
1	oxidized low density lipoproteinIBA 12/2009
1	Pioglitazone (Actos)FDA Link 08/2008
1	PPAR gammaIBA 08/2008
1	p38 Mitogen-Activated Protein KinasesIBA 08/2008
1	NF-kappa B (NF-kB)IBA 08/2008
1	NF-KappaB Inhibitor alphaIBA 08/2008
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2007
1	Superoxide Dismutase-1IBA 02/2007
1	2-butenal (crotonaldehyde)IBA 02/2007
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2006
1	AldehydesIBA 01/2006
1	LipidsIBA 01/2006
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2006
1	Transcription Factors (Transcription Factor)IBA 01/2006
1	4-oxo-2-nonenalIBA 01/2006
1	4-hydroxy-2-hexenalIBA 09/2004
1	Immunoglobulin G (IgG)IBA 09/2004
1	ImmunosorbentsIBA 09/2004

Therapy/Procedure

5	Therapeutics 07/2022 - 05/2014
1	Renal Dialysis (Hemodialysis) 09/2022
1	Renal Replacement Therapy (Therapies, Renal Replacement) 09/2022
1	Telescopes 07/2022